Home > News > 454 Life Sciences Receives $2.4 million NIH Grant
May 19th, 2004
454 Life Sciences Receives $2.4 million NIH Grant
Abstract:
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation today announced that the Company has received a two-year, $2.4 million grant from the National Human Genome Research Institute, one of the National Institutes of Health. The grant will help fund the scale up of 454 Life Sciences' technology toward sequencing of larger genomes.
Source:
PRNewswire
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||